Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3. This marks the third consecutive time Abt has earned a place on the vehicle, continuing its longstanding support for CMS and the Center for Medicare and Medicaid Innovation.
Through RMADA 3, Abt will help CMS design, implement, evaluate, and communicate evidence-based approaches to improve healthcare quality, strengthen program performance, and reduce costs. Abt’s experience spans Medicare payment systems, alternative payment models, data analytics, implementation support, and participant and public communications.
“Winning a seat on RMADA 3 reflects the trust CMS has placed in Abt to bring rigorous evidence, practical implementation experience, and innovation to complex healthcare challenges,” said ZeAmma Brathwaite, Vice President, U.S. Domestic Healthcare, Abt Global. “We understand where CMMI has been and how to help CMS move quickly as its priorities evolve—delivering actionable insights and solutions that support better outcomes for the people CMS serves.”
Abt’s work under prior RMADA vehicles has helped CMS streamline model implementation, use data more effectively, and communicate results to decision-makers, healthcare stakeholders, and the public. On RMADA 3, Abt will continue bringing full-service capabilities across research, analytics, digital solutions, technical assistance, and communications to help CMS advance its mission.
